All Vaccinology articles
-
NewsYour nose is a battlefield
Scientists have discovered that FluMist can trigger an immune response directly in nasal tissue in adults. The vaccine trains immune cells in the upper nasal passages to recognize and fight influenza virus infection. This immune response stays in the upper airways and can’t be detected via blood samples.
-
NewsVaccine strategy induces broadly neutralising HIV antibodies
Researchers have developed a new vaccine strategy that has generated antibodies capable of neutralising highly divergent HIV variants. The study provides new insights into how the immune system can be guided towards a particularly protected part of the virus.
-
NewsNew study suggests seasonal flu vaccines may reduce severity of H5N1 bird flu infections
Researchers have found that seasonal influenza vaccines in routine global use may significantly reduce the risk of death from H5N1 infection. The findings that readily available tools may offer protection while the world races to develop more targeted solutions.
-
NewsNew study suggests reduced newborn hepatitis B vaccination coverage may increase infant infections
Researchers found that lower vaccination coverage among infants born to unscreened mothers was associated with a substantial increase in HBV infections.
-
NewsWhere people get their news influences their beliefs about vaccines
People who follow “new right” media outlets are more than twice as likely to be vaccine-hesitant compared to those who never engage with those outlets, a new study finds. Hesitant adults were more likely to rely on non-authoritative sources for health information.
-
NewsGlobal Virus Network statement on H5N1 vaccine developments
The new vaccine momentum reflects the growing urgency of avian influenza (H5N1) threat and reinforces the need for coordinated global preparedness.
-
NewsSeparating signal from noise: How African biostatisticians are reshaping the fight against malaria
Biostatistics is unlocking smarter malaria solutions, linking parasite diversity, vaccines, and human behaviour to drive more effective prevention and protection.
-
NewsScientists highlight the cost of delaying childhood vaccination
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life. A new study found that the longer the delay, the higher the cost in human life and health care.
-
NewsResearchers develop promising new vaccine against H5N1 bird flu
Researchers have developed a vaccine approach that shows promise in protecting against highly pathogenic bird flu, demonstrating strong efficacy in both mice and cattle. In 2024, the virus spread to dairy cattle and subsequently caused illness in about 70 farm workers with close contact to infected animals.
-
NewsNew study examines measles vaccination coverage after a postelimination outbreak
In 2022–2023, a large postelimination measles outbreak occurred in central Ohio. A study found that 20 months after the outbreak, MMR coverage across the entire primary care network (PCN) population remained well below herd immunity levels, with minimal gains.
-
OpinionReversing the threat: How to stop measles from spreading again
As the Global Virus Network issues a stark warning over the significant resurgence of measles in the US and globally, William J. Moss, Sten H. Vermund, and Maggie L. Bartlett set out what needs to be done if the preventable harms of the current surge are to be reversed.
-
NewsFlu vaccine no longer required for U.S. military
The U.S. military is ending its long-standing requirement that service members receive the annual flu shot, a decision announced by Defense Secretary Pete Hegseth.
-
NewsRising measles cases highlight gaps in vaccination coverage and public health system vulnerabilities
The Global Virus Network (GVN) is closely monitoring a significant resurgence of measles in the United States and globally, reflecting a growing vulnerability in public health systems.
-
NewsMaternal RSV vaccination cuts infant hospitalization risk by over 80%, major study finds
The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.
-
NewsThree European countries reach 90% HPV vaccination target as Europe steps up action on cancer prevention
All EU/EEA countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s’ cancer prevention efforts. Iceland, Portugal and Norway have reached the target of 90% HPV vaccination coverage among girls by the age of 15.
-
NewsMeasles vaccine gaps persist among ER patients
A study has found critical gaps in knowledge, vaccination status, and acceptance of the measles, mumps, and rubella (MMR) vaccine among patients visiting emergency departments across the United States. It examines how misinformation and access barriers may contribute to declining vaccination rates.
-
FeaturesClinical considerations for the next pandemic: challenges facing Japan and strategic preparedness
Multiple global pandemics over the past century – the Spanish influenza (1918), Asian influenza (1957), Hong Kong influenza (1968), H1N1 influenza (2009), and COVID‑19 (since 2019) – have increasingly underscored the necessity for healthcare systems worldwide to be resilient, rapidly responsive, and forward‑facing.
-
NewsExtend vaccination opportunities and involve community members in communicating about vaccines to boost uptake, say researchers
Extending vaccination opportunities, involving community members alongside healthcare professionals in communicating about vaccines, and providing financial incentives are among the most effective ways to increase vaccine uptake.
-
NewsA closer look at immune ‘memory’ - and how long it lasts
A new review shares recent advances from the field of immune memory and highlights key steps we might take to develop even more effective, longer-lasting immunity against deadly diseases.
-
NewsResearchers uncover how obesity impairs vaccine response
New findings reveal that obesity significantly impaired the quality and longevity of antibody responses to a Pseudomonas aeruginosa vaccine in a mouse model. The impaired antibody production was due to defects in germinal centers.